Reiko Yoshino

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer

Kyoichi Kaira, Yoshio Tomizawa, Reiko Yoshino et al. · Lung Cancer · 2013 · 22 citations

Radiation Therapy, Medicine, Concurrent Radiotherapy +8

First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations

Tomohito Kuwako, Hisao Imai, Tomomi Masuda et al. · Cancer Chemotherapy and Pharmacology · 2015 · 22 citations

First-line Gefitinib Treatment, Elderly Patients, Medicine +8

Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene

Reiko Yoshino, Hisao Imai, Keita Mori et al. · Molecular and Clinical Oncology · 2014 · 21 citations · Full text

Advanced Nsclc, Overall Survival, Tumor Shrinkage +13

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations

Tomomi Masuda, Hisao Imai, Tomohito Kuwako et al. · Clinical & Translational Oncology · 2015 · 14 citations

First-line Gefitinib Treatment, Medicine, Platinum Combination Chemotherapy +8

Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy

Hisao Imai, Kyoichi Kaira, Keita Mori et al. · SpringerPlus · 2015 · 11 citations · Full text